Fertilization and early embryo development take place in the oviduct in vivo. Relative to studies in other reproductive organs, the importance of the oviduct has been ignored for many years because pregnancies can be obtained in assisted reproduction treatment using in-vitro fertilization (IVF) and embryo transfer to the uterus without involving the Fallopian tube. After the reports on the bene®cial effect of oviductal cells on embryo development in sheep 1 and subsequently in human, 2 and a practical need to improve the success rates in clinical assisted reproduction, there was a period when more research was performed on the Fallopian tube. Many of these studies used in vitro coculture systems to emulate the in vivo environment in vitro, and to search for oviduct-derived embryotrophic factors. With the recent development of sequential culture 3 to improve embryo development in vitro, the use of coculture in assisted reproduction and its related research declined because routine use of coculture is laborious and experience-dependent.
INTRODUCTION
Fertilization and early embryo development take place in the oviduct in vivo. Relative to studies in other reproductive organs, the importance of the oviduct has been ignored for many years because pregnancies can be obtained in assisted reproduction treatment using in-vitro fertilization (IVF) and embryo transfer to the uterus without involving the Fallopian tube. After the reports on the bene®cial effect of oviductal cells on embryo development in sheep 1 and subsequently in human, 2 and a practical need to improve the success rates in clinical assisted reproduction, there was a period when more research was performed on the Fallopian tube. Many of these studies used in vitro coculture systems to emulate the in vivo environment in vitro, and to search for oviduct-derived embryotrophic factors. With the recent development of sequential culture 3 to improve embryo development in vitro, the use of coculture in assisted reproduction and its related research declined because routine use of coculture is laborious and experience-dependent.
Despite this, evidence is now accumulating to suggest that this organ is not a passive conduit for gametes and embryos. Before fertilization, it is well accepted that the oviduct serves as a sperm reservoir in several animal species. 4, 5 Although there is no direct evidence for such a function in human Fallopian tube in vivo, in vitro experiments have demonstrated that human spermatozoa bind to the tubal epithelial cells. 6 In addition, human oviductal cells affect sperm functions in vitro. [7] [8] [9] After fertilization, the oviduct provides the microenvironment for early embryonic development. This review intends to provide an update on this postfertilization role of the oviduct, with a particular emphasis on human reproduction.
There is only limited evidence to show which of the oviductal changes are important for embryonic development because it is dif®cult to change each of these parameters independent of the others in vivo and to study the effect of such changes on embryo development. Moreover, the effect of the oviduct on embryo development IGF, insulin-like growth factor; R, receptor; IGFBP, insulin-like growth factor binding protein; TGF, transforming growth factor; EGF, epidermal growth factor; GM-CSF, granulocyte-macrophage colony-stimulating factor; VEGF, vascular endothelial growth factor; PDGF, platelet-derived growth factor; IL, interleukin; IL-1ra, Interleukin-1 receptor antagonist; CSF, colony stimulating factor; LIF, leukaemia inhibitory factor; c-fms, colony stimulating factor receptor; TNF, tumor necrosis factor; c-kit, stem cell factor receptor; SCF, stem cell factor; gp130, a component of LIF and IL-6 receptor. Reference numbers are shown in superscript.
The oviduct and development of the preimplantation embryo is facilitatory and not obligatory, making the detection of oviductal embryotrophic effects more dif®cult. Nevertheless, there is circumstantial evidence mainly from animal studies showing that the oviduct plays a fundamental role in early embryo development. This evidence is reviewed below.
CYCLICAL CHANGE OF OVIDUCTAL ACTIVITY
Changes in the ciliated and secretory cells of the primate oviduct are well documented across the reproductive cycle. 10 These changes are regulated by steroids, such that estrogen induces hypertrophy, maturation and an increase in cell height of nonciliated secretory oviductal epithelial cells and can partially restore ciliated phenotype in vitro. 11 These, together with cyclical morphological and physiological variations in the uterus, suggest that these two organs are actively involved in early reproductive events, and that they offer a dynamic microenvironment for the development of preimplantation embryos. The presence of growth factors in the oviduct and the corresponding receptors in the preimplantation embryo or vice versa suggests possible mechanisms of interaction between the oviduct and the embryo. The expression of growth factors in the preimplantation embryo and oviduct has recently been reviewed. 12, 13 Table 1 updates their occurrence in human oviduct and preimplantation embryos at protein and mRNA levels. Many of the growth factors in the oviduct are produced in a cyclical manner. Epidermal growth factor (EGF)/transforming growth factor-a (TGF-a) and their receptors have been extensively studied in the Fallopian tube and human embryo. The mRNA and protein expression of EGF and TGF-a are intense in the ampullary epithelium at late follicular and luteal stages but weak at the early follicular stage. 14, 15 Their receptor (EGFR) at the protein level is present in 8-to 14cell embryos. 16 On the other hand, EGFR is also found in the Fallopian tube with an expression pattern similar to its ligands. 17 Human embryos also secrete TGF-a into the culture medium; the secretion increases as the embryos develop to morula and blastocyst. 18 A similar situation exists for the insulin-like growth factor (IGF) system, with expression of the ligand and receptor found in both the Fallopian tube and the early embryo. 16, 19, 20 Although the addition of some of these factors stimulates embryo development in vitro, 21 it is uncertain whether these signaling systems are performing paracrine and/or autocrine function in vivo.
OVIDUCTAL MICROENVIRONMENT AND EMBRYO DEVELOPMENT
It is generally accepted that the oviduct may have evolved to provide an optimum microenvironment for early embryo development. An early preimplantation embryo is bathed in oviductal¯uid. Therefore, knowledge on the content of the oviductal uid is important. The composition of oviductal¯uid has been reported in many animal species. Interested readers are referred to reviews by Leese, 22 Hamner and
24
WSB Yeung, CKF Lee and JS Xu 26, 27 Postovulatory 139±148 mM 26, 27 Different stages 130 mM 168 Fox, 23 and Menezo and Guerin. 24 Recently, Leese and coworkers 25 provided an excellent review on the formation of oviductal¯uid. It is not the intention of this article to review all the components reported in the oviductal¯uid. Table 2 contains some of the reported compositions of oviductal¯uid from humans and primates. Similar to many other species, the oviductal¯uid in the primate is rich in K + and HCO 3 ± when compared with plasma. 26±28 Estrogen appears to stimulate the production of oviductal¯uid, as the greatest volume of oviductal¯uid in human and monkeys was observed at midcycle, coincident with the estrogen peak. 29, 30 It has been suggested that estrogen may modulate the movement of ions across the oviductal epithelium and, thereby, in¯uence the rate of¯uid secretion. 25 These data are consistent with an active regulation of oviductal function at the time of fertilization and early embryo development.
The nutrient requirement of the embryo changes as it grows. The importance of amino acids and nutrients to early preimplantation embryo development has been critically reviewed. 31, 32 Similar to many other animal species, human embryos consume pyruvate throughout the preimplantation period, and they use an increasing amount of glucose at compaction and blastocyst formation. 33, 34 In fact, a high level of glucose inhibits early embryonic development in a number of species including human. 35 The concentrations of nutrients in the oviduct differ from those in plasma, and vary with the endocrine state. 36 The concentration of glucose in human Fallopian tube¯uid decreases sixfold between the follicular phase and midcycle. 36 It was speculated that the decrease in glucose concentration of oviductal¯uid from mated pig when compared to unmated pig 37 was a strategy of the oviduct to protect embryos from exposure to a high concentration of glucose. 34 The importance of optimal Ovulation & luteal 57±61 mmHg nutrient concentrations is also re¯ected in experiments on sheep 38 and mouse 39 showing that embryo culture media based on nutrient concentrations in oviductal uid are superior to conventional media in supporting embryo development in vitro. Similarly, the embryo has a differential requirement for amino acids at different stages of development, 40 and media based on the amino acid content of oviductal uid improve ovine blastocyst formation and hatching. 41 Apart from simple organic and inorganic molecules, the oviduct synthesizes and releases a number of macromolecules. Interested readers are referred to reviews by Buhi and coworkers. 42, 43 Like many other animal species, the biosynthetic activity of the Fallopian tube increases at midcycle in the human. 43 In pig and sheep, it has been further shown that biosynthetic activity is higher in the ampulla than it is in the isthmus. 44, 45 Some secretory proteins from the human Fallopian tube¯uid, including oviduct-speci®c glycoprotein (OGP), 46 corticosteroid-binding globulin-like protein, 47 and insulin-like growth factor-binding protein 3 48 may be involved in fertilization and early embryonic development. Three high molecular weight embryotrophic glycoprotein fractions that stimulate mouse embryo development 49 have recently been isolated from human-oviductal-cell-conditioned medium. 50 The exact identities of these factors remain to be determined, but it is believed that these molecules are responsible for maternal-embryonic cross-talk during early preimplantation development. 51 OGP is one of the major macromolecules secreted by the oviduct. The protein has been characterized in several species, including rhesus, 52 baboon 53 and human. 54 In human, OGP is localized to the secretory granules of oviductal cells in both the ampulla and isthmus regions. 55 The human OGP gene 54 and its promoter 56 have been cloned and characterized. The presence of OGP around the time of ovulation suggests that it may play a role in fertilization and/or early embryonic development. 46, 57 In hamster, the molecule attaches to the ovulated oocyte and early embryo, 46, 58, 59 and also associates with the blastomeres. 60, 61 Although the physiological role of OGP is unclear, the chitinase-like domains of OGP are believed to interact with the oligosaccharide moieties of the zona pellucida, thereby forming a protective shield around the oocyte and early embryo. 58 
HORMONAL EFFECTS ON OVIDUCTAL EMBRYOS
It is generally believed that progesterone is essential for inducing the changes in the oviduct and uterus necessary for embryo viability and implantation. Administration of an anti-progesterone antibody to mice at 32 hours postcoitum retarded embryonic development; most of the embryos remained at the 4-cell stage whereas the control embryos were at the 8-cell to morula stage at 54±58 hours postcoitum. 62 The antibody treatment also induced a change in wheatgerm-lectin binding sites in the oviductal ampulla at days 3 and 4 of pregnancy, 63 but did not have noticeable effect on cultured mouse embryos. 62 A similar conclusion was reached using the anti-progestin, RU486, in mice. 64, 65 The oviduct and development of the preimplantation embryo However, the data on RU486 have to be interpreted with caution as this antiprogestin inhibits the development of mouse embryos in vitro. 66, 67 RU486 also affects oviductal embryo transport in this species. 68 Using a dose that did not affect the development of cynomolgus monkey embryos in vitro, 69 RU486 administration on day 2 after the presumed day of ovulation retarded preimplantation embryo growth in rhesus monkey. 70 The retarded embryos had abnormal morphology 71 and did not implant after transfer to naturally synchronized surrogate recipients. 70 Apart from progesterone, estradiol may also affect embryo development indirectly via its effect on oviductal secretion. Two-cell mouse embryos cultured in oviductal uid from estrogen-dominated donors were signi®cantly less able to develop to morula or blastocyst and to implant than those cultured in either control medium or the progesterone-dominated oviductal¯uid. 72 No inhibitory effect was observed on embryo development when estradiol or progesterone was added directly to the control medium. Estradiol may exert its action by affecting growth factor signalling systems in the oviduct. It induces oviductal mRNA expression of IGF-I in rat 73 and EGF, TGF-a, and EGF receptor in human. 17, 74 
EFFECTS OF OVIDUCTAL CELLS ON EMBRYO DEVELOPMENT IN VITRO
The above evidence demonstrates that the microenvironment in the oviductal¯uid affects early preimplantation embryo development. However, the actual contribution of the oviductal cells on embryo development is uncertain, as the components in the oviductal¯uid can be derived from plasma transudation and not solely from active secretion from the oviduct. It has been demonstrated that coculture of human embryos with human Fallopian tube cells improves the quality of the developing embryos. 2, 75, [75] [76] [77] As these studies provide more direct evidence that oviductal cell activities do contribute to the embryotrophic effect of the oviduct, this aspect is discussed in greater detail below.
COCULTURE STUDIES IN CLINICAL IVF
There have been a number of clinical coculture trials using oviductal cells of human or bovine origin in assisted reproduction. Table 3 summarizes the results of these studies. Most of the studies are prospective randomized clinical trials. Apart from one study, coculture with oviductal cells improved embryo quality and/or enhanced pregnancy rate/implantation rate. For some unknown reason, Tucker and coworkers 78 found no bene®cial effect of oviductal cells for couples requiring intracytoplasmic sperm injection (ICSI). However, the indication for ICSI and whether couples were undergoing IVF for the ®rst time were not mentioned. In addition to the clinical studies listed in Table 3 , there are other in vitro experiments demonstrating that oviductal cells decreased embryo fragmentation, 76 increased blastulation rate, 76, 79 the number of cells per blastocyst, 79 and the hatching rate of human embryos. 75 
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It has been suggested that oviductal cell coculture is suitable for poor prognosis patients, such as patients of advanced age, 80 patients with multiple failed IVF attempts, 80, 81 and patients with a high basal level of follicle stimulating hormone. 82 Coculture may not be required for young (<35 years) ®rst-time IVF patients as there is no difference in pregnancy rates in these patients with or without coculture, though the development of the embryos is improved after coculture. 83 This group of patients with a good prognosis is likely to produce suf®ciently good quality embryos that are competent to development in vitro.
LIMITATIONS OF COCULTURE STUDIES
Although oviductal cell coculture intends to imitate the in vivo condition, this objective cannot be achieved with the current model because the culture requirements of the somatic cells and the embryos are different. In a coculture system, only one culture medium, commonly the embryo culture medium, is used. Thus, the somatic cells are grown under suboptimal conditions. Walter 84 concluded that monolayers of bovine oviduct epithelial cells could not fully substitute for the oviduct epithelium when used in coculture experiments. Thus, cultured somatic cells may not function optimally in a coculture system.
To improve the ef®ciency of coculture, optimization of coculture conditions is important. In our experience the best coculture system using human oviductal cells with Earles' balanced salt solution is when the cells are at the rapidly growing phase. We usually seed 5610 4 cells in a 4-well plate and the cells will be ready to use the next day. Wiemer and coworkers 83 reported similar observations with bovine oviductal epithelial cells. They suggested that con¯uent cells and actively dividing noncon¯uent monolayers might secrete different levels of embryotrophic factors, and that steroid treatment affected the plating ef®ciency of bovine oviductal cells. 83 Con¯uent oviductal cell culture will cause the detachment and death of epithelial cells, leading to an increase in the acidity of the medium which is deleterious to embryo development.
During coculture, the observed effects on embryo development are the consequence of two opposing activities; namely, the embryotrophic effect of somatic cells and the combined deleterious effect of excretory waste from the somatic cells, proteases released by the somatic cells as a result of cell death and inappropriate competition of nutrients between the somatic cells and the embryos. This was shown in one of our unpublished experiments (Liu LPS and Yeung WSB) in which mouse embryos were cultured in spent media after culturing the oviductal cells for different durations and in media containing only the high molecular weight embryotrophic fraction of the conditioned media. Figure 1 shows the results of the experiment. Conditioned medium had its maximal embryotrophic effect after 6±9 hours of conditioning, but became inhibitory after 24 hours. On the other hand, the embryotrophic effect of the high molecular weight factors accumulated with time, reaching a plateau after 6 hours of conditioning. It has been reported that cocultured embryos are subjected to dynamic changes of growth factors/cytokines released by Vero cells 85 and that the culture condition will affect the secretion of growth factors by the cells. 86 The results of a number of reports on the use of somatic cells other than oviductal cells for coculture with human embryos are much more variable. Assisted reproduction without the involvement of the Fallopian tube can give rise to live birth, indicating that the coculture embryotrophic effect is facilitatory and not obligatory to embryo development. In many coculture studies, the embryos were cocultured for only 1±2 days. This short coculture period may not be suf®cient to induce an effect that can be manifested as an increase in pregnancy rate. The embryotrophic effect is further diminished when the number of somatic cells available, e.g. granulosa cells, is limited. Therefore, it is likely to be more dif®cult to demonstrate an increase in pregnancy rates in these studies. 87 Despite the general observation of enhanced embryo development after oviductal cell coculture, it is not used in most human assisted reproduction programmes because of the complexity of its implementation as a routine service and the limitations listed above. In addition, there is risk of transfer of disease from contaminated cultures to the embryos during coculture. 88 A safer and more practical approach is to produce a chemically de®ned embryo culture system. 89 Consequently, the recent development of the sequential culture, the use of different culture media for culturing embryos at different stages of development, has rapidly become the method of choice for improving the outcome in human assisted reproduction programmes. 3 Coculture and sequential culture are not mutually exclusive, and in fact they can complement each another. The human Fallopian tube produces granulocyte-macrophage colony-stimulating factor (GM-CSF) with a peak expression in the preimplantation period. 90 GM-CSF has recently been shown to improve human embryo development in the G1.2/G2.2 sequential culture medium system. 91 Its receptor mRNA is present in mouse embryos at all stages of development. 92 These data suggest that the present sequential culture system is not yet optimal, and that we can further improve the system by studying the mechanisms by which oviductal cells improve embryo development. Indeed, new sequential media may obviate the need for coculture.
OVIDUCTAL EMBRYOTROPHIC MECHANISMS
The exact mechanisms of oviductal embryotrophic activity in vivo are unclear. Most of the information in this area is based on in vitro coculture studies. However, the use of coculture to study oviductal embryotrophic mechanisms in human embryo development is dif®cult because the availability of human embryos for research is limited for ethical reasons. Very often mouse embryos are used instead.
Characterization of oviductal embryotrophic mechanisms using coculture faces two problems. The ®rst is that oviductal cells produce minute amount of embryotrophic factors making characterization of these factors dif®cult. The problem is aggravated as human oviductal cells have a limited proliferative life span in culture, posing more dif®culty in isolating suf®cient embryotrophic factors. We have recently established an immortalized human oviductal cell line 93 that retains most of the characteristics of primary oviductal cells including the production of OGP and some embryotrophic factors. In future, this cell line will be a valuable tool for studying the interaction between oviductal cells and embryos.
The second problem arises because the actions of oviductal embryotrophic factors are only facilitatory to embryonic development. In coculture experiments using mouse embryos, the ability to detect embryotrophic activity is often low because the development of many mouse strains does not require additional support in standard culture conditions for blastulation, the usual endpoint in these studies. In order to increase the sensitivity of detection, we use a mouse strain with low developmental potential in commonly used mouse culture media to assess the coculture embryotrophic effect. With this model, we detect the presence of three embryotrophic factors, termed ETF-1, -2, -3, in spent medium after human oviductal cell culture. 49, 50 There are three proposed mechanisms of embryotrophic activity in coculture; namely, positive conditioning, negative conditioning and cell-to-embryo contact. Positive conditioning refers to the production of embryotrophic factors by the somatic cells. During preimplantation embryo development, numerous peptide growth factors, their corresponding receptors and binding proteins are expressed in the oviduct of human, mouse and other domestic animals ( Table 1 ). The expression of many of these growth factors, e.g. IGF-1, 19,94 IGF-2, 19 TGF-a, EGF 14, 17 (full names of IGF, TGFa and EGF can be found on p. 22), is highest from mid-cycle to the early luteal phase, a time when the preimplantation embryo is in the oviduct. Many of the corresponding growth factor receptors are also expressed in the embryos within this period. Paracrine interaction between the oviduct and human preimplantation embryos via growth factors is indicated by the observation that addition of growth factors, e.g. IGF-1 21 , leukaemia inhibitory factor (LIF) 95 or heparin binding-epidermal growth factor, 96 to the culture medium facilitates human embryo development in vitro. Apart from growth factors, OGP binds to the zona pellucida and blastomeres of hamster embryo, 61 suggesting a possible role of this molecule in early embryo development. Hunter 97 proposed that oviduct glycoproteins might increase the viscosity of luminal¯uid, thereby preventing the dispersal of essential nutrients and ions and stabilizing the microenvironment immediately surrounding the embryos. However, this is dif®cult to test in vivo as the oviduct plays only a facilitatory role in embryo development.
It is unknown how the embryotrophic factors affect embryo development. When compared to embryos cultured in medium alone, human oviductal cell coculture affects the gene expression pro®les of mouse embryos, 98 and reduces the incidence of apoptosis at the morula and blastocyst stage. 99 Human 19, 21, 94 and bovine 100 oviductal cells express IGF-1. Exogenous IGF-I improved human embryo development partly by decreasing the incidence of blastomere apoptosis in the treated embryos, 101 leading to an increase in the number of cells within the inner cell mass. 21 Our recent data show that human oviductal cells produce three embryotrophic factors, ETF-1, -2 and -3 in vitro. 50 These factors are unlikely to be common growth factors as they have much larger molecular sizes. The stimulatory activity of ETF-3 on mouse blastulation is unaffected by antibodies against TGF-a, TGF-b, IGF-II, IGFBP3 (Xu and Yeung, unpublished observations). These factors have differential spatial and temporal effects on the development of mouse embryos. 102 Thus, ETF-1 and ETF-2 treatment covering the period of 48±72 hours after human chorionic gonadotrophin injection (hCG) increased cell numbers in the inner cell mass of the resulting blastocyst, whilst ETF-3 treatment covering 96±120 hours post-hCG increased the cell number in the trophectoderm. The improved development of trophectoderm after ETF-3 treatment resulted in larger blastocysts that hatched, attached to and spread on culture dishes more often than was seen in untreated controls. These results suggest that the response of embryos to embryotrophic factors changes as the embryos develop. We are currently investigating whether the response of the embryos to ETF-3 treatment is affected by prior treatment with ETF-1 and -2. In this connection, human endometrial stromal cells enhance the expression of IGF receptors in cocultured human embryos, 103 which might then become more sensitive to subsequent IGF treatment.
It is believed that conventional embryo culture conditions are not optimal. Negative conditioning refers to the removal of the suboptimal culture condition by coculture with somatic cells, leading to improved embryo development. The level of superoxide anion in culture medium is signi®cantly reduced by human oviductal cell coculture. 104 Bovine oviductal cells improve embryo development partly by altering
The oviduct and development of the preimplantation embryo the carbohydrate concentrations in the culture medium. 105 However, this embryotrophic mechanism is likely to be an artefact in vitro and may not represent the situation in vivo. Somatic cell-to-embryo contact has been shown to be unimportant in human oviductal cells coculture. 106 However, contradictory observations have also been reported. 104 Although various cell types exert embryotrophic activity on embryonic development in vitro, they may act via distinct mechanisms. Different cell types secrete different growth factors. Human oviductal cells express EGF, LIF, colony stimulating factor-1 and interleukin-6 (IL-6) while buffalo rat liver cells do not express LIF and IL-6. 107 Vero cells, but not human oviductal cells, improve mouse embryo development partly by altering the concentration of nutrients in the culture medium. 108 Therefore, it is surprising that the ef®cacy of coculture is different among the somatic cells used. In cattle, oviductal epithelial cell coculture produces better embryos than does coculture with granulosa cells, 109 oviductal stromal cells or endometrial epithelial cells. 110 The post-transfer development of bovine embryos is also better for embryos after coculture with oviductal cells than it is with those after coculture with bovine fetal uterine ®broblasts. 83 Although both sheep oviductal cells and ®broblast coculture stimulate embryo development in vitro, the development of sheep embryos after transfer following oviductal coculture is superior to that of embryos after ®broblast coculture. 1 Similarly, we also found that human oviductal epithelial cells were better than oviductal ®broblast in enhancing mouse blastulation. 49 In a prospectively randomized study, coculture with human ®broblasts did not improve embryo quality and pregnancy rate when compared to conventional medium alone. 111 
EFFECTS OF EMBRYO ON OVIDUCTAL ACTIVITY
Most of the coculture studies investigate the effect of oviductal cells on embryo development. There are some reports demonstrating that the embryos also affect oviductal physiology in animals. Although similar reports of humans are lacking, the machinery for such interaction has been demonstrated in human oviduct and embryos, suggesting that similar activity may also be present.
In mice, the vasculature of the oviduct containing 2-cell embryos is different to that in pseudopregnant mice without embryos. 112 Platelet activating factor (PAF) may be involved in these vascular changes. 112 PAF is produced by early embryos from a number of species including mouse, 113, 114 sheep 115 and human. 116 It alters several aspects of the maternal physiology during early pregnancy including systemic platelet count (inducing thrombocytopenia 116 ) and endometrial prostaglandin secretion. 117 The presence of the PAF receptor has recently been reported in human Fallopian tube 118 and bovine oviduct. 119 PAF increases the potential difference and short-circuit current when applied to the apical surface of human oviduct 120 and increases the intracellular free calcium concentration 121 and proliferation 122 in bovine oviductal cells in culture.
Fertilized embryos are transported down the oviduct at a faster rate than unfertilized ova in hamsters, 123 rat, 124 bats 125 and mares. 126 Evidence suggests that the development of embryos in¯uences the timing of their entrance to the uterus in the rat. 124 Equine embryos secrete prostaglandin E 2 immediately before and during the expected time of transport from oviduct to the uterus. 127 Prostaglandin E 2 has been shown to hasten this transport in the mare. 128 In hamsters, PAF stimulates oviductal transport of embryos, 129 probably by stimulating the frequency of the ciliary beat in oviductal cells. 130, 131 Similar data are not available for humans. TGFb-1 mRNA expression in mice is high in the 8-cell embryo and morula, but drops signi®cantly at the blastocyst stage. 132 However, the functional receptor for this growth factor can only be detected in the blastocyst. This suggests that the production of TGFb-1 by the early embryo before compaction may be relevant to its paracrine action on the oviduct. This is supported by our detection of TGFb-1 receptor expression in the oviduct throughout preimplantation embryo development. There are also indications that intra-oviductal embryos can exert a biological effect on the uterus, enhancing endometrial receptivity. 133 It is unlikely that an oviductal embryo with a few blastomeres is able to produce suf®cient quantities of active components to affect the physiology of other organs. In fact, embryo-derived PAF has a systemic effect on thrombocytopenia in early pregnancy. 134 It is more likely that embryoderived factors affect the nearby oviductal cells, which amplify the embryonic signal and modify the physiology of the maternal system. Embryos have been shown to stimulate the production of IGFBP-3 by human oviductal cells. 48 A similar conclusion was reached in a mouse embryo/human endometrial cell coculture system. 135 
CONCLUSION
The reproductive tract creates a dynamic environment for the optimal development of mammalian embryos in vivo. In nature, all embryos are exposed to the oviductal microenvironment after fertilization. Data suggest that the oviductal environment is important for the development of embryos and that there is complex cross-talk between embryos and the oviduct. The best available medium today contains only a small subset of the components present in the oviductal environment. Although the embryo can adapt to its environment, 34, 136 the inadequacy of the medium inevitably causes stress to the cultured embryos. 137 This may be one reason for the low success rate in clinical assisted reproduction. To improve this situation, improved knowledge of the oviductal microenvironment is crucial. Unfortunately, information on this aspect is rather limited.
Coculture is a good model, though with some pitfalls, for giving clues to the possible mechanisms of interaction between the embryo and the oviduct. Its utilization in clinical assisted reproduction has generated some controversy. 138, 139 The arguments against its use include the fact that coculture is not chemically de®ned, making interpretation dif®cult, and coculture embryotrophic effects may only represent a remedy for artefacts created by conventional suboptimal culture conditions. 89, 140 The pursuit of speci®c oviduct factors in coculture and the con®rma-
The oviduct and development of the preimplantation embryo tion of the embryotrophic activity by adding these factors to chemically de®ned medium would help to solve the controversy. Future work should focus on the normal physiology and biochemistry of the oviduct and the early embryo.
A word of caution for the supplementation of only some embryotrophic factors to the embryo culture medium is necessary. Some embryotrophic factors have speci®c effects on certain cell types of embryos. For instance, ETF-3 affects mainly trophectoderm cells. The effect of a selective increase in the development of trophectoderm on subsequent fetal development remains to be determined. In this context, it has been reported that larger calves are born after coculture with tubal cells, 141, 142 and that the percentage of male calves is increased after coculture with bovine oviduct epithelial cells and Vero cells. 143 Rigorous controlled studies will be necessary before suggesting the application of media supplemented with embryotrophic factors to clinical assisted reproduction.
